Asia Pacific Vaccines Market Growth, Size, Share, Trends, Key Players Analysis, and Forecast till 2031
Asia Pacific Vaccines Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Conjugated Vaccines, Inactivated Vaccines, Live Vaccines, Recombinant Vaccines, and Toxoid Vaccines), Indication (HPV, PCV, DTP, Hepatitis, Influenza, Dengue, and Other), Route of Administration (Injection, Oral, and Other), and Age Group (Pediatric and Adult)
- Report Date : Nov 2025
- Report Code : TIPRE00005749
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 207
The Asia Pacific Vaccines Market size is expected to reach US$ 22,940.5 Million by 2031 from US$ 15,065.1 Million in 2024. The market is estimated to record a CAGR of 6.2% from 2025 to 2031.
Executive Summary and Asia Pacific Vaccines Market Analysis:Asia Pacific has solidified its position as a leading hub for vaccine research and development, leveraging its advantages in cost-efficiency, diverse demographics, and rapid participant recruitment rates. With a significant share in both prophylactic and therapeutic vaccine trials, the region demonstrates strategic importance in shaping the future of global vaccine innovation. According to the Global Health Press, Asia Pacific leads the world with 46% of global prophylactic vaccine trials and 31% of therapeutic vaccine trials, surpassing other regions in both trial volume and operational efficiency.
Additionally, extensive public health campaigns and universal immunization goals have contributed to higher vaccine coverage rates. Additionally, the need for pandemic preparedness in the wake of COVID-19 has intensified investments in research and development, as well as manufacturing capacity. The region's improving healthcare infrastructure and well-established cold chain logistics ensure the efficient storage and distribution of vaccines, even to remote areas.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Asia Pacific Vaccines Market: Strategic Insights
| Market Size Value in | US$ 7,254.5 Million in 2018 |
| Market Size Value by | US$ 12,631.4 Million by 2027 |
| Growth rate | CAGR of 6.4% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- By Type, the Asia Pacific Vaccines Market is segmented into Conjugated Vaccines, Inactivated Vaccines, Live Vaccines, Recombinant Vaccines, and Toxoid Vaccines. The Conjugated Vaccines segment held the largest share of the market in 2024.
- By Indication, the Asia Pacific Vaccines Market is segmented into HPV, PCV, DTP, Hepatitis, Influenza, Dengue, and Other. The HPV segment held the largest share of the market in 2024.
- By Route of Administration, the Asia Pacific Vaccines Market is segmented into Injection, Oral, and Other. The injection segment held the largest share of the market in 2024.
- By Age Group, the Asia Pacific Vaccines Market is segmented into Pediatric and Adult. The pediatric segment held the largest share of the market in 2024.
The World Health Organization (WHO) has identified over 30 priority pathogens that could lead to global public health emergencies. These include influenza A viruses, dengue virus, and monkeypox virus. Recently, there has been a global increase in the frequency of infectious disease outbreaks in humans. These outbreaks are caused by bacteria and viruses, most of which originate in animals or are transmitted by vectors. According to the Influenza Surveillance and Response System (GISRS) from sentinel surveillance locations, SARS-CoV-2 activity has increased globally. As of May 11, 2025, the test positivity rate was 11% across 73 reporting countries, regions, and territories. This rate is comparable to the peak observed in July 2024, which was 12% from 99 countries, and represents an increase from the 2% reported by 110 countries in mid-February 2025.
As of April 2024, the WHO reported over 7.6 million dengue cases, including 3.4 million confirmed cases, over 16,000 severe cases, and more than 3,000 deaths. Currently, 90 countries are experiencing active dengue transmission.
According to the Council on Foreign Relations, during 2022-2023, a global mpox outbreak resulted in 87,000 reported cases and 140 confirmed deaths across 111 countries. WHO declared the outbreak a Public Health Emergency of International Concern (PHEIC).
According to the WHO, in 2022, ~254 million people were living with hepatitis B, and 50 million with hepatitis C. Half of those affected by chronic hepatitis B and C infections were aged between 30 and 54 years, while 12% were children under 18 years old. Across all regions, only 13% of individuals with chronic hepatitis B infection had been diagnosed, and about 3% (i.e., ~7 million) had received antiviral therapy by the end of 2022. For hepatitis C, 36% had been diagnosed, and 20% (i.e., roughly 12.5 million) had received curative treatment. Hepatitis is preventable through vaccination, and various organizations are proposing strategies to prevent premature deaths from hepatitis. As per the WHO estimates, 4.5 million deaths can be prevented in low- and middle-income countries by 2030. WHO Member States are endorsing the WHO's global hepatitis strategy with an aim to reduce new hepatitis infections by 90% and deaths by 65% by 2030.
Outbreaks of contagious diseases significantly increase the public and government demand for vaccines. When diseases such as measles, dengue, or COVID-19 emerge or spread rapidly, the urgency to control the outbreak drives up the demand for vaccinations. For example, the global COVID-19 pandemic created unprecedented demand for vaccines worldwide, with both governments and individuals seeking rapid immunization to curb the spread of the virus and reduce mortality rates. As per the WHO, global immunization efforts have saved an estimated 154 million lives over the past 50 years, which translates to the equivalent of six lives saved every minute each year. The measles vaccination had the most significant impact on reducing infant mortality, accounting for 60% of the lives saved through immunization. As of April 2024, 84% of infants were protected with three doses of vaccine against diphtheria, tetanus, and pertussis (DTP), which serves as the global benchmark for immunization coverage.
Therefore, the surging prevalence of infectious diseases and rising vaccine-preventable disease outbreaks increase the demand for vaccines.
Asia Pacific Vaccines Market Country InsightsBy country, the Asia Pacific Vaccines Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. China held the largest share in 2024.
China is gearing up to supply the world with affordable vaccines that fulfil all efficacy, safety, and quality requirements. China has come a long way since 1978, when it introduced an expanded program on immunization (EPI), and a largely state-run vaccine manufacturing industry grew up to meet the resulting demand. China is currently producing nearly all of the commonly used vaccines for viral diseases such as influenza, measles, rabies (for humans), mumps, rotavirus, hepatitis A and B, and for bacterial diseases, including typhoid, tetanus, and diphtheria.
The first respiratory syncytial virus (RSV) prophylaxis for all infants, Levitra/Beyfortus (nisevizumab injection), a long-acting monoclonal antibody jointly developed by Sanofi and AstraZeneca, has been formally approved for marketing by the National Medical Products Administration (NMPA) of China and is expected to be available in China during 2024-2025. With a single injection, it can provide timely, rapid, and direct immunoprotection against RSV-induced lower respiratory tract infections for all infants (healthy/special health status, full-term/premature, born inside and outside of the season of infection).
Chinese companies such as AIM Vaccine Co., Ltd. are advancing mRNA vaccines, including those targeting RSV, and developing combination vaccines, reflecting a trend toward innovative vaccine platforms.
Asia Pacific Vaccines Market Company ProfilesSome of the key players operating in the market includeAbbott Laboratories, GSK Plc, Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, CSL Ltd, Serum Institute of India Pvt Ltd, BioNTech SE, and Sinovac Biotech Ltd.
These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Asia Pacific Vaccines Market Research MethodologyThe following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites,
annual reports, financial statements, broker analyses, and investor presentationsIndustry trade journals
and other relevant publicationsGovernment documents,
statistical databases, and market reportsNews articles,
press releases, and webcasts specific to companies operating in the market
Note:
All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.Primary Research
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
- Validate and refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders:
Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales ManagersExternal experts:
Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Disease Indication, Route of Administration, Patient Type, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Vaccines Market Landscape
4.1 Market Overview
4.2 PEST Analysis
5. Asia Pacific Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. Vaccines Market - Asia Pacific Market Analysis
6.1 Asia Pacific Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Vaccines Market Forecast and Analysis
7. Asia Pacific Vaccines Market Revenue Analysis - by Type
7.1 Conjugated
7.1.1 Overview
7.1.2 Conjugated: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated
7.2.1 Overview
7.2.2 Inactivated: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Live
7.3.1 Overview
7.3.2 Live: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Recomb
7.4.1 Overview
7.4.2 Recomb: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Toxoid
7.5.1 Overview
7.5.2 Toxoid: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. Asia Pacific Vaccines Market Revenue Analysis - by Indication
8.1 HPV
8.1.1 Overview
8.1.2 HPV: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 PCV
8.2.1 Overview
8.2.2 PCV: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 DTP
8.3.1 Overview
8.3.2 DTP: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Hepatitis
8.4.1 Overview
8.4.2 Hepatitis: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Influenza
8.5.1 Overview
8.5.2 Influenza: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.6 Dengue
8.6.1 Overview
8.6.2 Dengue: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.7 Other
8.7.1 Overview
8.7.2 Other: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. Asia Pacific Vaccines Market Revenue Analysis - by Route Of Administration
9.1 Injection
9.1.1 Overview
9.1.2 Injection: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oral
9.2.1 Overview
9.2.2 Oral: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Other
9.3.1 Overview
9.3.2 Other: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. Asia Pacific Vaccines Market Revenue Analysis - by Age Group
10.1 Pediatric
10.1.1 Overview
10.1.2 Pediatric: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Adult
10.2.1 Overview
10.2.2 Adult: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. Asia Pacific Vaccines Market - Country Analysis
11.1 Asia Pacific
11.1.1 Asia Pacific Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.1.1 Asia Pacific Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.2.2 China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 China: Asia Pacific Vaccines Market Share - by Type
11.1.2.2.2 China: Asia Pacific Vaccines Market Share - by Indication
11.1.2.2.3 China: Asia Pacific Vaccines Market Share - by Route Of Administration
11.1.2.2.4 China: Asia Pacific Vaccines Market Share - by Age Group
11.2.3.3 Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 Japan: Asia Pacific Vaccines Market Share - by Type
11.2.3.3.2 Japan: Asia Pacific Vaccines Market Share - by Indication
11.2.3.3.3 Japan: Asia Pacific Vaccines Market Share - by Route Of Administration
11.2.3.3.4 Japan: Asia Pacific Vaccines Market Share - by Age Group
11.3.4.4 India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 India: Asia Pacific Vaccines Market Share - by Type
11.3.4.4.2 India: Asia Pacific Vaccines Market Share - by Indication
11.3.4.4.3 India: Asia Pacific Vaccines Market Share - by Route Of Administration
11.3.4.4.4 India: Asia Pacific Vaccines Market Share - by Age Group
11.4.5.5 Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4.5.5.1 Australia: Asia Pacific Vaccines Market Share - by Type
11.4.5.5.2 Australia: Asia Pacific Vaccines Market Share - by Indication
11.4.5.5.3 Australia: Asia Pacific Vaccines Market Share - by Route Of Administration
11.4.5.5.4 Australia: Asia Pacific Vaccines Market Share - by Age Group
11.5.6.6 South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.5.6.6.1 South Korea: Asia Pacific Vaccines Market Share - by Type
11.5.6.6.2 South Korea: Asia Pacific Vaccines Market Share - by Indication
11.5.6.6.3 South Korea: Asia Pacific Vaccines Market Share - by Route Of Administration
11.5.6.6.4 South Korea: Asia Pacific Vaccines Market Share - by Age Group
11.6.7.7 Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.6.7.7.1 Rest of APAC: Asia Pacific Vaccines Market Share - by Type
11.6.7.7.2 Rest of APAC: Asia Pacific Vaccines Market Share - by Indication
11.6.7.7.3 Rest of APAC: Asia Pacific Vaccines Market Share - by Route Of Administration
11.6.7.7.4 Rest of APAC: Asia Pacific Vaccines Market Share - by Age Group
12 Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 Industry Landscape
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GSK Plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Pfizer Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck & Co Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Sanofi SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 CSL Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Serum Institute of India Pvt Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BioNTech SE
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sinovac Biotech Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
List of Tables
Table 1. Asia Pacific Vaccines Market Segmentation
Table 2. List of Vendors
Table 3. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 6. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 7. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 8. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 10. China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 11. China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 12. China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 13. Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 14. Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 15. Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 17. India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 19. India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 20. India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 21. Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 22. Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 23. Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 24. Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 25. South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 26. South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 27. South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 28. South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 29. Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 30. Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 31. Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 32. Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 33. Heat Map Analysis by Key Players
List of Figures
Figure 1. Asia Pacific Vaccines Market Segmentation - Country
Figure 2. PESTAnalysis
Figure 3. Ecosystem: Vaccines Market
Figure 4. Asia Pacific Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Vaccines Market Share (%) - by Type, 2024 and 2031
Figure 8. Conjugated: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Live: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Recomb: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Toxoid: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Asia Pacific Vaccines Market Share (%) - by Indication, 2024 and 2031
Figure 14. HPV: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. PCV: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. DTP: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Hepatitis: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Influenza: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Dengue: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Other: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Asia Pacific Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Injection: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Oral: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Other: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Asia Pacific Vaccines Market Share (%) - by Age Group, 2024 and 2031
Figure 26. Pediatric: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Adult: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Asia Pacific Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 29. China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Company Positioning & Concentration
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Nov 2025
dPCR Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
Nov 2025
Oscillometry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Device and Accessories), Technology (Impulse Oscillometry, Forced Oscillation Technique, and Hybrid Oscillometry Devices), Application (Asthma, COPD, and Others), End User (Hospitals, Diagnostic Laboratories, and Others)
Nov 2025
Prenatal Testing Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Diagnostic Type (Noninvasive and Invasive), Disease (Aneuploidy, Microdeletions, Structural Chromosomal Abnormalities, and Others), End User (Hospitals, Diagnostic Laboratories, Specialty Clinics, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Nov 2025
Joint Resurfacing Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Knee, Hip, Shoulder, Ankle, and Others), Material (Metal, Ceramic, and Others), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America)
Nov 2025
Embolization Plugs Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Neurology, Peripheral Vascular Disease, Oncology, Urology, and Others), End User (Hospital, Ambulatory Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Nov 2025
Aesthetic Exosomes Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human-derived, Animal-derived, and Plant-derived), Route of Administration (Topical and Injectable), Application (Skin Rejuvenation, Wrinkle Reduction and Fine Line Correction, Scar and Pigmentation, Post-procedure Recovery, Hair Restoration, and Others), and End User (Hospitals, Dermatology Clinics, Medical Spas, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Nov 2025
Carrier Testing Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and Other Medical Conditions), End User (Hospital-Based Laboratories, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Nov 2025
Natural Albumin Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human Serum Albumin, Bovine Serum Albumin, and Plant Serum Albumin), Application (Therapeutic Applications, Drug Delivery, Disease Diagnostics, Research, and Others Applications), and End User (Hospitals and Clinics, Pharmaceutical and Biotechnological Companies, Research Institutes, Diagnostic Laboratories, Homecare Settings, and Others)
Get Free Sample For